1,1,3,3,5,5,7,7,9,9,11,11,13,13,15,15-Hexadecamethyloctasiloxane, 98%, 1g

Fmoc-Lys(Ac)-OH, 97%, 250mg

5-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)furan-2-carbaldehyde, 97.0%, 10g

Petri dishes square, Sterile 240 pcs

1,4-Dioxane (stabilized with BHT)>99.0%(GC)500g

1-Difluoromethyl-4-nitro-1H-pyrazole, 95.0%, 500g

[1-(1H-benzimidazol-2-yl)-1-methylethyl]amine dihydrochloride, 95.0%, 250mg

2-(Methylthio)pyrimidine-5-carboxylic acid, 95.0%, 25g

7-Bromo-3-(2-chloro-5-(trifluoromethyl)pyrimidin-4-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-indole-6-carbonitrile, 97%, 250mg

Ammonium nitrate matrix modifier solution, 50 g/L NH4NO3 (99.999%) in H2O, 50 mL

1-Chloro-2-ethoxy-3-fluorobenzene, 5g

Bixin, 98.81%, 5mg

2-Iodo-3-methoxy-6-methylpyridine, 95.0%, 250mg